A dual origin for blood vessels.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. From blueprint to build: Metal ions in peripheral nerve development and engineering regeneration.Bioactive materials · 2026
   Review
2. Animals : an open access journal from MDPI · 2026
   Article
3. The biofunctionalization of titanium nanotube with chitosan/genipin heparin hydrogel and the controlled release of IL-4 for anti-coagulation and anti-thrombus through accelerating endothelialization.RSC advances · 2021
   Article
4. The Formation of Coronary Vessels in Cardiac Development and Disease.Cold Spring Harbor perspectives in biology · 2020
   Review
5. Molecular regulation of arteriovenous endothelial cell specification.F1000Research · 2019
   Review

Corrections and comments

• Comment on
  Erythro-myeloid progenitors contribute endothelial cells to blood vessels.2018

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as